Patents Assigned to M.G. THERAPEUTICS LTD
  • Compositions and methods for the treatment of meibomian gland dysfunction
    Patent number: 10034887
    Abstract: Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such as salicylic acid, selenium disulfide, or the like. Topical administration of said compositions to the eyelid margin or surrounding areas provides therapeutic benefit to patients suffering from meibomian gland dysfunction.
    Type: Grant
    Filed: September 19, 2016
    Date of Patent: July 31, 2018
    Assignee: M.G. THERAPEUTICS, LTD.
    Inventors: Yair Alster, Omer Rafaeli, K. Angela MacFarlane, Cary Reich, Shimon Amselem, Doron Friedman
  • Compositions and methods for the treatment of meibomian gland dysfunction
    Patent number: 9463201
    Abstract: Described herein are compositions and methods for the treatment of meibomian gland dysfunction. Said compositions and methods comprise keratolytic agents, such as salicylic acid, selenium disulfide, or the like. Topical administration of said compositions to the eyelid margin or surrounding areas provides therapeutic benefit to patients suffering from meibomian gland dysfunction.
    Type: Grant
    Filed: June 5, 2015
    Date of Patent: October 11, 2016
    Assignee: M.G. THERAPEUTICS LTD
    Inventors: Yair Alster, Omer Rafaeli, K. Angela Macfarlane, Cary Reich, Shimon Amselem, Doron Friedman